...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR virtual meeting June22nd

So no info on the Breast trial at this meeting.

Share
New Message
Please login to post a reply